CHD7 maintains neural stem cell quiescence and prevents premature stem cell depletion in the adult hippocampus

KM Jones, N Sarić, JP Russell, CL Andoniadou… - Stem …, 2015 - academic.oup.com
KM Jones, N Sarić, JP Russell, CL Andoniadou, PJ Scambler, MA Basson
Stem cells, 2015academic.oup.com
Neural stem/progenitor cells (NSCs) in the hippocampus produce new neurons throughout
adult life. NSCs are maintained in a state of reversible quiescence and the failure to
maintain the quiescent state can result in the premature depletion of the stem cell pool. The
epigenetic mechanisms that maintain this quiescent state have not been identified. Using an
inducible knockout mouse model, we show that the chromatin remodeling factor
chromodomain–helicase-DNA-binding protein 7 (CHD7) is essential for maintaining NSC …
Abstract
Neural stem/progenitor cells (NSCs) in the hippocampus produce new neurons throughout adult life. NSCs are maintained in a state of reversible quiescence and the failure to maintain the quiescent state can result in the premature depletion of the stem cell pool. The epigenetic mechanisms that maintain this quiescent state have not been identified. Using an inducible knockout mouse model, we show that the chromatin remodeling factor chromodomain–helicase-DNA-binding protein 7 (CHD7) is essential for maintaining NSC quiescence. CHD7 inactivation in adult NSCs results in a loss of stem cell quiescence in the hippocampus, a transient increase in cell divisions, followed by a significant decline in neurogenesis. This loss of NSC quiescence is associated with the premature loss of NSCs in middle-aged mice. We find that CHD7 represses the transcription of several positive regulators of cell cycle progression and is required for full induction of the Notch target gene Hes5 in quiescent NSCs. These findings directly link CHD7 to pathways involved in NSC quiescence and identify the first chromatin-remodeling factor with a role in NSC quiescence and maintenance. As CHD7 haplo-insufficiency is associated with a range of cognitive disabilities in CHARGE syndrome, our observations may have implications for understanding the basis of these deficits. Stem Cells  2015;33:196–210
Oxford University Press